Clarus Therapeutics Holdings Inc. (NASDAQ: CRXT) kicked off on June 22, 2022, at the price of $0.3509, up 18.95% from the previous trading day. During the day, the shares moved up to $0.437 and dropped to $0.3509 before settling in for the closing price of $0.36. Over the past 52 weeks, CRXT has traded in a range of $0.33-$31.24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Sponsored
While this was happening, its average annual earnings per share was recorded -251.70%.
In an organization with 16 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +80.51, operating margin of -284.67, and the pretax margin is -291.02.
Clarus Therapeutics Holdings Inc. (CRXT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Clarus Therapeutics Holdings Inc. is 2.40%, while institutional ownership is 33.80%.
Clarus Therapeutics Holdings Inc. (CRXT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/30/2021, the organization reported -$0.19 earnings per share (EPS), higher than consensus estimate (set at -$0.68) by $0.49. This company achieved a net margin of -291.02 while generating a return on equity of -332.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -251.70% per share during the next fiscal year.
Clarus Therapeutics Holdings Inc. (NASDAQ: CRXT) Trading Performance Indicators
Take a look at Clarus Therapeutics Holdings Inc.’s (CRXT) current performance indicators. Last quarter, stock had a quick ratio of 0.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of Clarus Therapeutics Holdings Inc. (CRXT)
Let’s dig in a bit further. During the last 5-days, its volume was 3.27 million. That was inferior than the volume of 7.9 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 36.11%. Additionally, its Average True Range was 0.06.
During the past 100 days, Clarus Therapeutics Holdings Inc.’s (CRXT) raw stochastic average was set at 2.55%, which indicates a significant decrease from 39.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.15% in the past 14 days, which was lower than the 235.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6694, while its 200-day Moving Average is $2.6395. However, in the short run, Clarus Therapeutics Holdings Inc.’s stock first resistance to watch stands at $0.4560. Second resistance stands at $0.4895. The third major resistance level sits at $0.5421. If the price goes on to break the first support level at $0.3699, it is likely to go to the next support level at $0.3173. Assuming the price breaks the second support level, the third support level stands at $0.2838.
Clarus Therapeutics Holdings Inc. (NASDAQ: CRXT) Key Stats
The company with the Market Capitalisation of 23.00 million has total of 52,021K Shares Outstanding. Its annual sales at the moment are 13,960 K in contrast with the sum of -40,620 K annual income. Company’s last quarter sales were recorded 4,010 K and last quarter income was -14,870 K.
